Ebr share price
WebMar 28, 2024 · The average price target for the stock over the next 12 months is $12.23, with the estimates having a low of $10.27 and a high of $14.01. These price ends are -59.47% and -117.55% off the today’s price level respectively, although investors could be excited at the prospect of a -86.96% if the EBR share price touches on the median … WebView today’s EBR share price, options, bonds, hybrids and warrants. View announcements, advanced pricing charts, trading status, fundamentals, dividend information, peer analysis and key company information.
Ebr share price
Did you know?
WebApr 13, 2024 · 6.3%. 10% least volatile stocks in BE Market. 2.6%. Stable Share Price: AED is not significantly more volatile than the rest of Belgian stocks over the past 3 months, typically moving +/- 4% a week. Volatility Over Time: AED's weekly volatility (4%) has been stable over the past year. WebApr 6, 2024 · 10% most volatile stocks in AU Market. 14.9%. 10% least volatile stocks in AU Market. 3.5%. Stable Share Price: EBR is not significantly more volatile than the rest of Australian stocks over the past 3 months, typically moving +/- 9% a week. Volatility Over Time: EBR's weekly volatility (9%) has been stable over the past year.
WebToday's EBR share price, stock chart and announcements. View dividend history, insider trades and ASX analyst consensus. WebDec 31, 2024 · NYSE: EBR Share price (4/11/23): $6.86 Market cap (4/11/23): $16.1 billion Categorized Chronological Ownership by Owner Insider Transactions Institutional Owners Transcripts ...
WebApr 11, 2024 · Mithra Pharmaceuticals SA was founded in 1999 and is headquartered in Liège, Belgium. Rewards. Risk analysis. Highly volatile share price over the past 3 months. Has less than 1 year of cash runway. Shareholders have been … WebMar 31, 2024 · Share I thought it would be interesting to consider poster's views on EBR share price valuation. Yes it's premature, as of end of March 2024. The company is still pre SOLVE CRT trial outcome, pre PMA application to the FDA, pre- commercialisation.
WebStock KBC Common Stock BE0003565737 XBRU Euronext Brussels Live Euronext quotes, realtime prices, charts and regulated news
WebApr 14, 2024 · What Is Viohalco's Net Debt? The image below, which you can click on for greater detail, shows that at December 2024 Viohalco had debt of €2.43b, up from €2.14b in one year. However, it also had €416.3m in cash, and so its net debt is €2.01b. ENXTBR:VIO Debt to Equity History April 14th 2024. bristol heart institute wardsWebApr 10, 2024 · Their EBR share price forecasts range from $70.00 to $70.00. On average, they expect the company's stock price to reach $70.00 in the next twelve months. This suggests a possible upside of 975.3% from the stock's current price. View analysts price targets for EBR or view top-rated stocks among Wall Street analysts. can you take cerelle with hrtWebFeb 19, 2024 · The EBR-acquired nameplate returns with plans for 10 new models. By Ben Purvis. February 19, 2024. ... Despite a deal that saw Indian firm Hero MotoCorp take a 49 percent share in EBR in 2013, the ... bristol heat network vattenfallWeb1 day ago · View Centrais Eltricas Brasileiras SA EBR investment & stock information. Get the latest Centrais Eltricas Brasileiras SA EBR detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. bristol health medworksWebThe current Centrais Eletricas Brasileiras SA share price is $6.57. The Score for EBR is 19, which is 62% below its historic median score of 50, and infers higher risk than normal. EBR is currently trading in the 10-20% percentile range relative to its historical Stock Score levels. Will Centrais ... can you take cetirizine and chlorpheniramineWebApr 5, 2024 · Investment Style Large Blend Day Range 6.46 – 6.56 Year Range 5.67 – 10.39 Market Cap 15.0192 Bil Volume / Avg 575,300.0 / 1.6 Mil Price / Sales 2.23 Price / Book 0.69 Forward Div Yield 2.30%... bristol heat raceWebApr 12, 2024 · Other metrics may better explain the share price move. The modest 0.6% dividend yield is unlikely to be guiding the market view of the stock. Arguably, the revenue drop of 6.0% a year for half a decade suggests that the company can't grow in the long term. That could explain the weak share price. bristol heights assisted living cda